Expression of estrogen receptors-α and -β in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy

Bulletin of Experimental Biology and Medicine

Volumn 138, Issue 5, 2004, Pages 494-496

  Bershtein, L M ^a   Poroshina, T E ^a   Zimarina, T S ^a   Tsyrlina, E V ^a   Zhil'tsova, E K ^a   Kovalevskii, A Yu ^a   Semiglazov, V F ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Breast cancer; Estrogen receptors and ; Hormonotherapy

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXEMESTANE; MESSENGER RNA; PROGESTERONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CONTROLLED STUDY; ESTROGEN SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOASSAY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NITRILES; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TAMOXIFEN; TRIAZOLES;

EID: 15544365684     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-005-0079-7     Document Type: Article

References (11)

1. L. M. Bershtein, T. S. Zimarina, T. E. Poroshina, et al., Byull. Eksp. Biol. Med., 136, No. 11, 550-552 (2003).
2. Aromatase Inhibition and Breast Cancer 2001 Eds. W. R. Miller and R. J. Santen Basel New York
3. Endocrine Therapy in Breast Cancer 2002 Eds. W. R. Miller J. N. Ingle Basel New York
4. G. Lazennec, D. Bresson, A. Lucas, et al., Endocrinology, 142, 4120-4130 (2001).
5. Y. Miyoshi, T. Taguchi, J. A. Gustafsson, and S. Noguchi, Jpn. J. Cancer Res., 92, 1057-1061 (2001).
6. Y. Omoto, S. Inoue, S. Ogawa, et al., Cancer Lett., 163, 207-212 (1998).
7. C. Palmieri, G. J. Cheng, S. Saji, et al., Endocr. Relat. Cancer, 9, No. 1, 1-13 (2002).
8. M. Saez, P. Martin, and C. D. Chouver, Cancer Res., 38, 3468-3473 (1978).
9. H. S. Seo, D. Larsimont, G. Querton, et al., Int. J. Cancer, 78, No. 6, 760-765 (1998).
10. V. Speirs, A. T. Parkes, M. Kerin, and S. L. Atkin, Cancer Res., 59, 525-528 (1999).
11. E. A. Vladusic, A. E. Hornby, F. K. Guerra-Vladusic, et al., Oncol. Rep., 7, No. 1, 157-167 (2000).